Guidelines for the Clinical Diagnosis and Treatment of Dengue, Chikungunya, and Zika
dc.date.accessioned | 2022 | |
dc.date.available | 2022 | |
dc.date.issued | 2022 | |
dc.identifier.citation | Guidelines for the Clinical Diagnosis and Treatment of Dengue, Chikungunya, and Zika. Washington, D.C.: Pan American Health Organization; 2022. License: CC BY-NC-SA 3.0 IGO. https://doi.org/10.37774/9789275124871. | en_US |
dc.identifier.isbn | 978-92-75-12488-8 (Print) | |
dc.identifier.isbn | 978-92-75-12487-1 (PDF) | |
dc.identifier.uri | https://iris.paho.org/handle/10665.2/55867 | |
dc.description.abstract | Evidence-based guidelines are one of the most useful tools for improving public health and clinical practice. Their purpose is to formulate interventions based on strong evidence of efficacy, avoid unnecessary risks, use resources efficiently, reduce clinical variability and, in essence, improve health and ensure quality care, which is the purpose of health systems and services. These guidelines were developed following the GRADE methodology, with the support of a panel of clinical experts from different countries, all convened by the Pan American Health Organization. By responding to twelve key questions about the clinical diagnosis and treatment of dengue, chikungunya, and Zika, evidence-based recommendations were formulated for pediatric, youth, adult, older adult, and pregnant patients who are exposed to these diseases or have a suspected or confirmed diagnosis of infection. The purpose of the guidelines is to prevent progression to severe forms of these diseases and the fatal events they may cause. The recommendations are intended for health professionals, including general, resident, and specialist physicians, nursing professionals, and medical and nursing students, who participate in caring for patients with suspected dengue, chikungunya, or Zika. They are also intended for health unit managers and the executive teams of national arboviral disease prevention and control programs, who are responsible for facilitating the process of implementing these guidelines. | en_US |
dc.language.iso | en | en_US |
dc.publisher | PAHO | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 IGO | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/igo/ | * |
dc.subject | Chikungunya virus | en_US |
dc.subject | Dengue Virus | en_US |
dc.subject | Communicable Diseases | en_US |
dc.subject | Clinical Diagnosis | en_US |
dc.subject | Dengue | en_US |
dc.subject | Zika Virus | en_US |
dc.subject | Arboviruses | en_US |
dc.subject | Pregnant Women | en_US |
dc.subject | Child | en_US |
dc.subject | Pediatrics | en_US |
dc.subject | Aged | en_US |
dc.subject | Communicable Disease Control | en_US |
dc.title | Guidelines for the Clinical Diagnosis and Treatment of Dengue, Chikungunya, and Zika | en_US |
dc.type | Procedures, manuals, guidelines | en_US |
dc.rights.holder | Pan American Health Organization | en_US |
dc.contributor.corporatename | Pan American Health Organization | en_US |
paho.isfeatured | 0 | en_US |
paho.publisher.country | United States | en_US |
paho.publisher.city | Washington, D.C. | en_US |
dc.identifier.doi | 978-92-75-12487-1 | |
paho.source.centercode | US1.1 | en_US |
paho.relation.languageVersion | 10665.2/55125 | en_US |
paho.contributor.department | Communicable Diseases and Environmental Determinants of Health (CDE) | en_US |
paho.iswhotranslation | No | en_US |